DE3371278D1
(en)
|
1982-06-14 |
1987-06-11 |
Merrill Edward Wilson |
Process and apparatus for measuring blood viscosity directly and rapidly
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
IL125071A0
(en)
|
1996-01-17 |
1999-01-26 |
Novo Nordisk As |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives their preparation and use
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
CA2264243C
(en)
|
1996-08-30 |
2004-10-05 |
Novo Nordisk A/S |
Glp-1 derivatives
|
DK0958296T3
(da)
|
1996-12-31 |
2003-08-18 |
Reddys Lab Ltd Dr |
Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
CA2294830A1
(en)
|
1997-07-16 |
1999-01-28 |
John Bondo Hansen |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
WO1999038501A2
(en)
|
1998-02-02 |
1999-08-05 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
ATE266659T1
(de)
|
1998-03-12 |
2004-05-15 |
Teijin Ltd |
Benzofurylpyron-derivate
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
CZ294029B6
(cs)
|
1998-12-07 |
2004-09-15 |
Societe De Conseils De Recherches Et D'application |
Analog GLP-1, jeho použití a farmaceutický prostředek jej obsahující
|
AUPP891299A0
(en)
|
1999-02-26 |
1999-03-25 |
Fujisawa Pharmaceutical Co., Ltd. |
New 6-membered cyclic compounds
|
WO2000063208A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
WO2000064884A1
(en)
|
1999-04-26 |
2000-11-02 |
Novo Nordisk A/S |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
HUP0200997A3
(en)
|
1999-04-28 |
2003-03-28 |
Sanofi Aventis Deutschland |
Tri-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them
|
DK1177187T3
(da)
|
1999-04-28 |
2007-10-15 |
Sanofi Aventis Deutschland |
Diarylsyrederivater som PPAR-receptorligander
|
WO2000066585A1
(en)
|
1999-04-30 |
2000-11-09 |
Neurogen Corporation |
9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
|
RU2261248C2
(ru)
|
1999-06-23 |
2005-09-27 |
Авентис Фарма Дойчланд Гмбх |
Замещенные бензимидазолы и лекарственное средство на их основе
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
DE50011035D1
(de)
|
1999-09-01 |
2005-09-29 |
Aventis Pharma Gmbh |
Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
WO2001017516A2
(en)
|
1999-09-10 |
2001-03-15 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
AU6985300A
(en)
|
1999-09-10 |
2001-04-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
JP2003509429A
(ja)
|
1999-09-10 |
2003-03-11 |
ノボ ノルディスク アクティーゼルスカブ |
タンパク質チロシンホスファターゼ(ptpアーゼ)のモジュレーター
|
WO2001021577A2
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
UA74367C2
(uk)
|
2000-03-23 |
2005-12-15 |
Сольве Фармас'Ютікалз Б.В. |
ПОХІДНІ 4,5-ДИГІДРО-1Н-ПІРАЗОЛУ, ЩО ВИЯВЛЯЮТЬ АНТАГОНІСТИЧНУ АКТИВНІСТЬ ЩОДО СВ<sub>1</sub>, СПОСІБ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЇЇ ВИГОТОВЛЕННЯ, СПОСІБ ЛІКУВАННЯ ЗАХВОРЮВАНЬ (ВАРІАНТИ)
|
KR100502876B1
(ko)
|
2000-04-28 |
2005-07-21 |
아사히 가세이 파마 가부시키가이샤 |
신규 이환성 화합물
|
CA2408343A1
(en)
|
2000-05-11 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU6497701A
(en)
|
2000-05-30 |
2001-12-11 |
Merck & Co Inc |
Melanocortin receptor agonists
|
WO2001096302A1
(en)
|
2000-06-16 |
2001-12-20 |
Smithkline Beecham P.L.C. |
Piperidines for use as orexin receptor antagonists
|
EP1246847A2
(en)
|
2000-07-05 |
2002-10-09 |
Synaptic Pharmaceutical Corporation |
Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
|
WO2002006245A1
(en)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmarceutical Corporation |
Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
|
PL365183A1
(en)
|
2000-07-31 |
2004-12-27 |
Smithkline Beecham P.L.C. |
Carboxamide compounds and their use as antagonists of a human 11cby receptor
|
ATE329901T1
(de)
|
2000-11-10 |
2006-07-15 |
Lilly Co Eli |
3-substituierte oxindolderivate als beta-3- agonisten
|
US20030022891A1
(en)
|
2000-12-01 |
2003-01-30 |
Anandan Palani |
MCH antagonists and their use in the treatment of obesity
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
MXPA03005606A
(es)
|
2000-12-21 |
2003-10-06 |
Vertex Pharma |
Compuestos de pirazol utiles como inhibidores de la proteina cinasa.
|
MXPA03005019A
(es)
|
2000-12-21 |
2003-09-25 |
Avantis Pharma Deutschland Gmb |
Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
|
IL156550A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
PE20020856A1
(es)
|
2001-02-13 |
2002-11-11 |
Aventis Pharma Gmbh |
1,2,3,4-tetrahidronaftil aminas aciladas
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
ES2229132T3
(es)
|
2001-03-22 |
2005-04-16 |
Solvay Pharmaceuticals B.V. |
Derivados de 4,5-dihidro-1h-pirazol que tienen actividad como antagonistas de cb1.
|
CA2446351A1
(en)
|
2001-05-04 |
2002-11-14 |
Tularik Inc. |
Fused heterocyclic compounds
|
EP1258247A1
(en)
|
2001-05-14 |
2002-11-20 |
Aventis Pharma Deutschland GmbH |
Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
EP1436435B1
(en)
|
2001-06-28 |
2010-04-14 |
Alonim Holding Agricultural Cooperative Society Ltd. |
Method of anodizing of magnesium and magnesium alloys and producing conductive layers on an anodized surface
|
WO2003007887A2
(en)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
AU2002331064B2
(en)
|
2001-08-10 |
2007-08-23 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
PL208515B1
(pl)
|
2001-08-31 |
2011-05-31 |
Sanofi Aventis Deutschland |
Pochodne diarylocykloalkilowe, środki lecznicze zawierające te związki oraz ich zastosowanie jako aktywatorów PPAR
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
WO2003026648A1
(en)
|
2001-09-21 |
2003-04-03 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
|
ATE344663T1
(de)
|
2001-09-21 |
2006-11-15 |
Solvay Pharm Bv |
Neue 4,5-dihydro-1h-pyrazol-derivate mit cb1- antagonistischer wirkung
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
GT200200188A
(es)
|
2001-09-24 |
2003-06-25 |
|
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
|
RU2004115737A
(ru)
*
|
2001-10-25 |
2005-10-10 |
Такеда Кемикал Индастриз, Лтд. (JP) |
Соединение хинолина
|
DE60236541D1
(de)
|
2001-11-22 |
2010-07-08 |
Biovitrum Ab |
Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
|
IL160648A0
(en)
|
2001-11-22 |
2004-07-25 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
CN1649855A
(zh)
|
2001-11-22 |
2005-08-03 |
比奥维特罗姆股份公司 |
11-β-羟基类固醇脱氢酶1型抑制剂
|
EP1450801A4
(en)
|
2001-11-27 |
2010-10-27 |
Merck Sharp & Dohme |
2-AMINOQUINOLINE COMPOUNDS
|
DE60317631T2
(de)
|
2002-02-01 |
2008-09-25 |
Merck & Co., Inc. |
11-beta-hydroxysteroid-dehydrogenase-1-hemmer zur behandlung von diabetes, adipositas und dyslipidämie
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
DE60301491T2
(de)
|
2002-02-27 |
2006-05-18 |
Pfizer Products Inc., Groton |
Acc-hemmer
|
CA2477967C
(en)
|
2002-03-05 |
2010-08-10 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
JP2005527586A
(ja)
|
2002-04-05 |
2005-09-15 |
メルク エンド カムパニー インコーポレーテッド |
置換アリールアミド
|
AU2003226928A1
(en)
*
|
2002-04-09 |
2003-10-27 |
7Tm Pharma A/S |
Novel aminotetraline compounds for use in mch receptor related disorders
|
WO2003087044A2
(en)
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
IL164249A0
(en)
|
2002-04-11 |
2005-12-18 |
Aventis Pharma Gmbh |
Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
|
WO2003086288A2
(en)
|
2002-04-12 |
2003-10-23 |
Merck & Co., Inc. |
Bicyclic amides
|
WO2003097047A1
(en)
|
2002-05-13 |
2003-11-27 |
Eli Lilly And Company |
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
|
WO2003097064A1
(fr)
|
2002-05-17 |
2003-11-27 |
Kyowa Hakko Kogyo Co., Ltd. |
Agent de traitement du diabète
|
US7595311B2
(en)
|
2002-05-24 |
2009-09-29 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
TWI329111B
(en)
|
2002-05-24 |
2010-08-21 |
X Ceptor Therapeutics Inc |
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
EP1375508A1
(en)
|
2002-06-27 |
2004-01-02 |
Aventis Pharma Deutschland GmbH |
N6-substituted adenosine analogues and their use as pharmaceutical agents
|
WO2004005324A2
(en)
|
2002-07-09 |
2004-01-15 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
OA12881A
(en)
|
2002-07-12 |
2006-09-15 |
Aventis Pharma Gmbh |
Heterocyclially substituted benzoylureas, method for their production and their use as medicaments.
|
MXPA05001009A
(es)
|
2002-07-27 |
2005-05-16 |
Astrazeneca Ab |
Cetonas.
|
ES2301833T3
(es)
|
2002-07-29 |
2008-07-01 |
Hoffmann La Roche |
Derivados de benzodioxol.
|
EP1539136B1
(en)
*
|
2002-07-30 |
2008-07-09 |
Merck & Co., Inc. |
Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
|
KR20050069977A
(ko)
|
2002-08-07 |
2005-07-05 |
미쯔비시 웰 파마 가부시키가이샤 |
디히드로피라졸로피리딘 화합물
|
DE10237723A1
(de)
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
DE10238865A1
(de)
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US20040242572A1
(en)
*
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
NZ539193A
(en)
|
2002-09-05 |
2008-04-30 |
Aventis Pharma Sa |
Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
|
JP2006505531A
(ja)
|
2002-09-11 |
2006-02-16 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのピペラジン尿素誘導体
|
EP1539746B1
(en)
|
2002-09-12 |
2006-11-15 |
F. Hoffmann-La Roche Ag |
N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
AU2003269242A1
(en)
|
2002-10-11 |
2004-05-04 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
|
BR0314872A
(pt)
|
2002-10-18 |
2005-08-02 |
Pfizer Prod Inc |
Ligandos do receptor canabinóide e usos dos mesmos
|
AU2003298596B2
(en)
|
2002-10-18 |
2008-12-18 |
Merck Sharp & Dohme Corp. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US7132539B2
(en)
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
CA2501228A1
(en)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
AU2003291342A1
(en)
|
2002-11-05 |
2004-06-07 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
AU2003276458A1
(en)
|
2002-11-07 |
2004-06-07 |
Astrazeneca Ab |
2-oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
WO2004058145A2
(en)
|
2002-12-19 |
2004-07-15 |
Merck & Co., Inc. |
Substituted amides
|
WO2004058727A1
(en)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
ATE506354T1
(de)
|
2003-01-06 |
2011-05-15 |
Lilly Co Eli |
Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
|
WO2004065380A1
(en)
|
2003-01-14 |
2004-08-05 |
Arena Pharmaceuticals Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
EP1594863A1
(en)
|
2003-02-11 |
2005-11-16 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
WO2004072076A1
(de)
|
2003-02-13 |
2004-08-26 |
Aventis Pharma Deutschland Gmbh |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
CA2514791A1
(en)
|
2003-02-13 |
2004-08-26 |
Aventis Pharma Deutschland Gmbh |
Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
|
PL378555A1
(pl)
|
2003-02-19 |
2006-05-02 |
F. Hoffmann-La Roche Ag |
Sulfonoamido-podstawione pochodne ksantyny do stosowania jako inhibitory PEPCK
|
WO2004078717A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
EP1610789B1
(en)
|
2003-03-26 |
2010-07-21 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
RU2345985C2
(ru)
|
2003-03-26 |
2009-02-10 |
Актелион Фармасьютиклз Лтд. |
Производные тетрагидроизохинолилацетамида в качестве антагонистов орексинового рецептора
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
EP1615697A2
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof
|
EP1618112A1
(en)
|
2003-04-11 |
2006-01-25 |
SmithKline Beecham Corporation |
Heterocyclic mchr1 antagonists
|
WO2004089367A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
WO2004089380A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of fused 1,2,4-triazoles
|
ATE467616T1
(de)
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
CN100472485C
(zh)
|
2003-04-25 |
2009-03-25 |
松下电器产业株式会社 |
服务器及服务器的处理方法
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
WO2004096763A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
|
WO2004096794A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
|
EA200501703A1
(ru)
|
2003-05-01 |
2006-06-30 |
Вернэлис Рисёч Лимитед |
Применение производных азетидинкарбоксамида в терапии
|
WO2004100875A2
(en)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions containing such compounds and methods of use
|
BRPI0410289A
(pt)
|
2003-05-07 |
2006-05-16 |
Pfizer Prod Inc |
ligantes do receptor de canabinóides e suas utilizações
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
WO2004103980A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
|
AU2004249120B2
(en)
|
2003-05-23 |
2008-07-24 |
Glaxosmithkline |
Guanidino-substituted quinazolinone compounds as MC4-R agonists
|
US8026264B2
(en)
|
2003-05-29 |
2011-09-27 |
Merck Sharp And Dohme Corp. |
Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
EP1636181A1
(en)
|
2003-06-11 |
2006-03-22 |
Merck & Co., Inc. |
Substituted 3-alkyl and 3-alkenyl azetidine derivatives
|
EA200600032A1
(ru)
|
2003-06-13 |
2006-06-30 |
Янссен Фармацевтика Н.В. |
Замещённые производные индазолил (индолил) малеимида в качестве ингибиторов киназ
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
EP1641779A1
(en)
|
2003-06-18 |
2006-04-05 |
AstraZeneca AB |
2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
|
GB0314057D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314049D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314261D0
(en)
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
WO2005000339A2
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Melanocortin receptor 4(mc4) agonists and their uses
|
EP1638556B1
(en)
|
2003-06-20 |
2008-04-02 |
F. Hoffmann-La Roche Ag |
2-aminobenzothiazoles as cb1 receptor inverse agonists
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
JP4501859B2
(ja)
|
2003-06-27 |
2010-07-14 |
日本電気株式会社 |
薄膜トランジスタ、薄膜トランジスタ基板、電子機器及び多結晶半導体薄膜の製造方法
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
WO2005000974A2
(en)
|
2003-06-27 |
2005-01-06 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
JP2007525470A
(ja)
|
2003-07-09 |
2007-09-06 |
フォーブス メディ−テック インコーポレーテッド |
ステロール及び/又はスタノール及びコレステロール生合成阻害剤を含む新規化合物及び組成物、並びに様々な疾患及び症状の治療又は防止へのそれらの使用
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005007628A1
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
AU2004259717A1
(en)
|
2003-07-22 |
2005-02-03 |
Merck & Co., Inc. |
Piperidine derivatives as melanocortin-4 receptor agonists
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
CA2534221A1
(en)
|
2003-08-07 |
2005-02-24 |
Merck & Co., Inc. |
Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
US20070072812A1
(en)
|
2003-08-25 |
2007-03-29 |
Microbia, Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
US20070161577A1
(en)
|
2003-08-28 |
2007-07-12 |
Martinez Eduardo J |
Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones
|
US20070105914A1
(en)
|
2003-09-18 |
2007-05-10 |
Armstrong Helen M |
Substituted sulfonamides
|
TWI336697B
(en)
|
2003-09-19 |
2011-02-01 |
Solvay Pharm Bv |
Thiazole derivatives as cannabinoid receptor modulators
|
US20070203058A1
(en)
|
2003-09-19 |
2007-08-30 |
Novo Nordisk A/S |
Novel Glp-1 Derivatives
|
RU2381233C2
(ru)
|
2003-09-30 |
2010-02-10 |
Ново Нордиск А/С |
Агонисты рецептора меланокортина
|
US20060247239A1
(en)
|
2003-10-01 |
2006-11-02 |
Hu Xiufeng E |
Melanin concentrating hormone antagonists
|
EP1667958A2
(en)
*
|
2003-10-01 |
2006-06-14 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
EP1522541A1
(en)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Novel hypocholesterolemic compounds
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
EP1682117A1
(en)
|
2003-10-30 |
2006-07-26 |
Merck & Co., Inc. |
2-azetidinones as anti-hypercholesterolemic agents
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
WO2005042692A2
(en)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
|
BRPI0416287A
(pt)
|
2003-11-07 |
2007-01-23 |
Hoffmann La Roche |
compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
|
WO2005047293A1
(en)
|
2003-11-07 |
2005-05-26 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
US7320972B2
(en)
|
2003-11-10 |
2008-01-22 |
Microbia, Inc. |
4-Biarylyl-1-phenylazetidin-2-ones
|
EP1685102A4
(en)
|
2003-11-12 |
2008-08-20 |
Lg Life Sciences Ltd |
melanocortin
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
MXPA06005736A
(es)
|
2003-11-19 |
2006-12-14 |
Chiron Corp |
Compuestos de quinazolinona con bioacumulacion reducida.
|
JP4922615B2
(ja)
|
2003-11-26 |
2012-04-25 |
武田薬品工業株式会社 |
受容体機能調節剤
|
EP1538159A1
(en)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
EP1694348A4
(en)
|
2003-12-10 |
2009-07-01 |
Merck & Co Inc |
VOLUNTARY INHIBITION OF CONSUMPTION OF ETHANOL USING MELANOCORTIN RECEPTOR 4 RECEPTOR AGONISTS
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
AU2004309368A1
(en)
|
2003-12-19 |
2005-07-14 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
TW200528455A
(en)
|
2003-12-19 |
2005-09-01 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
EP1697370B1
(en)
|
2003-12-19 |
2007-04-25 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
JP2007514794A
(ja)
|
2003-12-19 |
2007-06-07 |
メルク エンド カムパニー インコーポレーテッド |
環式グアニジン、そのような化合物を含む組成、及び使用方法
|
AU2004308932A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc |
Aryl sulfonamide compounds and uses related thereto
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
WO2005062824A2
(en)
|
2003-12-23 |
2005-07-14 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
ATE485267T1
(de)
|
2003-12-23 |
2010-11-15 |
Astrazeneca Ab |
Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
|
NZ547965A
(en)
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
ATE367161T1
(de)
|
2004-01-06 |
2007-08-15 |
Janssen Pharmaceutica Nv |
(3-oxo-3,4-dihydro-chinoxalin-2-yl-amino)- benzamid-derivate und verwandte verbindungen als glykogen-phosphorylase-hemmer zur behandlung von diabetes und adipositas
|
ES2349195T3
(es)
|
2004-01-28 |
2010-12-28 |
F. Hoffmann-La Roche Ag |
Espiro-benzodioxoles y su uso como antagonistas de cb1.
|
AU2005209365A1
(en)
|
2004-01-31 |
2005-08-11 |
Sanofi-Aventis Deutschland Gmbh |
7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
EP1720847A1
(en)
|
2004-02-02 |
2006-11-15 |
Pfizer Products Incorporated |
Histamine-3 receptor modulators
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
JP2007522255A
(ja)
|
2004-02-17 |
2007-08-09 |
ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ |
置換アゼチジン化合物、その製造および医薬品としての使用
|
AU2005214137B2
(en)
|
2004-02-18 |
2008-05-29 |
Astrazeneca Ab |
Compounds
|
RU2357958C2
(ru)
|
2004-02-19 |
2009-06-10 |
Солвей Фармасьютикалс Б.В. |
Производные имидазолина, обладающие cb1-антагонистической активностью
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
EP1718617B1
(en)
|
2004-02-20 |
2009-08-19 |
AstraZeneca AB |
3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
|
WO2005080424A2
(en)
|
2004-02-23 |
2005-09-01 |
Rheoscience A/S |
Peptide yy analogues
|
US7902191B2
(en)
|
2004-02-25 |
2011-03-08 |
Eli Lilly And Company |
Histamine H3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
AU2005219779B2
(en)
|
2004-03-04 |
2011-04-14 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
CA2555914A1
(en)
|
2004-03-08 |
2005-09-22 |
Amgen Inc. |
Therapeutic modulation of ppar (gamma) activity
|
EA009455B1
(ru)
|
2004-03-10 |
2007-12-28 |
Янссен Фармацевтика Н.В. |
Ингибирующие mtp арилпиперидины или пиперазины, замещенные 5-членными гетероциклами
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2005230864A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck Sharp & Dohme Corp. |
Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
JP2007531744A
(ja)
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6−アザインドール化合物
|
WO2005097738A1
(ja)
|
2004-04-06 |
2005-10-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規スルホンアミド誘導体
|
WO2005097076A2
(en)
|
2004-04-09 |
2005-10-20 |
Smithkline Beecham Corporation |
Low dose pharmaceutical products
|
US20050256124A1
(en)
|
2004-04-15 |
2005-11-17 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
WO2005108370A1
(ja)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
ベンゼン化合物
|
CN1950359A
(zh)
|
2004-05-12 |
2007-04-18 |
安万特药物公司 |
作为IkB激酶抑制剂的基本纯净的2-{ [2-(2-甲基氨基-嘧啶-4-基)-1H-吲哚-5-羰基]-氨基}-3-(苯基吡啶-2-基-氨基)-丙酸
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
WO2005118573A1
(en)
|
2004-05-28 |
2005-12-15 |
Smithkline Beecham Corporation |
Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
KR20070041452A
(ko)
|
2004-06-24 |
2007-04-18 |
일라이 릴리 앤드 캄파니 |
이상지혈증 치료를 위한 화합물 및 방법
|
WO2006001318A1
(ja)
|
2004-06-24 |
2006-01-05 |
Shionogi & Co., Ltd. |
スルホンアミド化合物
|
AU2005267331A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
EP1773780A4
(en)
|
2004-06-24 |
2008-01-09 |
Incyte Corp |
AMIDO COMPOUNDS AND USES THEREOF AS PHARMACEUTICAL PRODUCTS
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
KR100926842B1
(ko)
|
2004-07-28 |
2009-11-13 |
에프. 호프만-라 로슈 아게 |
11-베타-hsd1 억제제로서의 아릴-피리딘 유도체
|
FR2873693B1
(fr)
|
2004-07-29 |
2006-09-15 |
Sanofi Synthelabo |
Derives d'amino-tropane, leur preparation et leur application en therapeutique
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7915252B2
(en)
|
2004-08-06 |
2011-03-29 |
Merck Sharp & Dohme |
Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
BRPI0514147A
(pt)
|
2004-08-12 |
2008-05-27 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento profilático ou terapêutico de uma condição onde a ativação de gk é desejável, de tratamento profilático ou terapêutico da hiperglicemia ou diabete e de prevenção da diabete em um ser humano que demosntra hiperglicemia pré-diabética ou toleráncia à glicose prejudicada, e, processo para a preparação do composto
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2008509982A
(ja)
|
2004-08-16 |
2008-04-03 |
プロシディオン・リミテッド |
アリール尿素誘導体
|
WO2006023515A2
(en)
|
2004-08-18 |
2006-03-02 |
Metabasis Therapeutics, Inc. |
Novel thiazole inhibitors of fructose 1,6-bisphosphatase
|
EA012263B1
(ru)
|
2004-08-30 |
2009-08-28 |
Янссен Фармацевтика Н.В. |
Производные n-2-адамантанил-2-феноксиацетамида в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
|
CN101018790A
(zh)
|
2004-09-11 |
2007-08-15 |
塞诺菲-安万特德国有限公司 |
7-氮杂吲哚以及其用作ppar激动剂的应用
|
EP1803729A4
(en)
|
2004-09-29 |
2008-10-01 |
Kissei Pharmaceutical |
HETEROCYCLIC NITROGENIC COMPOUND 1- (-D-GLYCOPYRANOSYL) -3-SUBSTITUTED, THERAPEUTIC PREPARATION CONTAINING SAID COMPOUND, AND MEDICAL USE OF SAID COMPOUND
|
CA2581865C
(en)
|
2004-09-29 |
2010-04-20 |
F. Hoffmann-La Roche Ag |
Indazolone derivatives as 11b-hsd1 inhibitors
|
JP4797021B2
(ja)
|
2004-10-01 |
2011-10-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダ−ゼ−iv阻害剤としてのアミノピペリジン
|
EP2330126B1
(en)
|
2004-10-07 |
2015-12-23 |
Novo Nordisk A/S |
Protracted exendin-4 compounds
|
EP1799710A2
(en)
|
2004-10-07 |
2007-06-27 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
EP1802623A1
(en)
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
US7550467B2
(en)
|
2004-10-12 |
2009-06-23 |
Schering Corporation |
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
JP2008517029A
(ja)
|
2004-10-22 |
2008-05-22 |
スミスクライン・ビーチャム・コーポレイション |
Hm74a受容体活性を有するキサンチン誘導体
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
SI1807072T1
(sl)
|
2004-10-29 |
2009-06-30 |
Lilly Co Eli |
Derivati cikloalkil laktamov kot inhibitorji 11-beta-hidroksisteroid dehidrogenaze 1
|
US20090093463A1
(en)
|
2004-11-02 |
2009-04-09 |
Agouron Pharmaceuticals Inc. |
Novel compounds of substituted and unsubtituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
WO2007024993A2
(en)
|
2005-08-26 |
2007-03-01 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
JP4999698B2
(ja)
|
2004-11-29 |
2012-08-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダーゼ−iv阻害剤としての縮合アミノピペリジン
|
JPWO2006059744A1
(ja)
|
2004-11-30 |
2008-06-05 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
WO2006058923A1
(en)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
JP5254620B2
(ja)
|
2004-12-03 |
2013-08-07 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Cb1アンタゴニストとしての置換ピペラジン
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
EP1888544A2
(en)
|
2004-12-17 |
2008-02-20 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
CA2591486A1
(en)
|
2004-12-18 |
2006-07-13 |
Bayer Healthcare Ag |
(5s) -3-[(s)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as cetp inhibitors
|
AR054417A1
(es)
|
2004-12-23 |
2007-06-27 |
Astrazeneca Ab |
Derivados de imidazol. proceso de obtencion y composiciones farmaceuticas.
|
WO2006067443A1
(en)
|
2004-12-23 |
2006-06-29 |
Astrazeneca Ab |
Therapeutic agents
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
US20080318922A1
(en)
|
2004-12-24 |
2008-12-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicyclic Pyrrole Derivatives
|
EP1838311A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
DK1848430T3
(da)
|
2004-12-31 |
2017-11-06 |
Dr Reddys Laboratories Ltd |
Nye benzylamin-derivativer som cetp-inhibitors
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
ES2386365T3
(es)
|
2005-01-05 |
2012-08-17 |
Abbott Laboratories |
Derivados de adamantilo como inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa de tipo 1
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
US7956061B2
(en)
|
2005-01-19 |
2011-06-07 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
JP2008528700A
(ja)
|
2005-02-03 |
2008-07-31 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Pparモジュレーターとしての化合物および組成物
|
JPWO2006085685A1
(ja)
|
2005-02-09 |
2008-06-26 |
武田薬品工業株式会社 |
ピラゾール化合物
|
WO2006086562A2
(en)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
SI1856090T1
(sl)
|
2005-02-11 |
2010-02-26 |
Lilly Co Eli |
Substituirani derivati tiofena kot antagonisti glukagonskega receptorja, priprava in terapevtske uporabe
|
GB0503053D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
WO2006085112A1
(en)
|
2005-02-14 |
2006-08-17 |
Smithkline Beecham Corporation |
Anthranilic acid derivatives as hm74a receptor agonists
|
GB0503056D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
US20080227792A1
(en)
|
2005-02-15 |
2008-09-18 |
Novo Nordisk A/S |
3,4-Dihydro-1H-Isoquinoline-2-Carboxylic Acid 5-Aminopyridin-2-Yl Esters
|
EP1849795B1
(en)
|
2005-02-15 |
2011-01-26 |
Kissei Pharmaceutical Co., Ltd. |
1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
AU2006217677A1
(en)
|
2005-02-25 |
2006-08-31 |
Takeda Pharmaceutical Company Limited |
Pyridyl acetic acid compounds
|
US20060229250A1
(en)
|
2005-03-09 |
2006-10-12 |
Jian Zhang |
Ghrelin associated peptide and its uses
|
JP4708474B2
(ja)
|
2005-03-09 |
2011-06-22 |
エフ.ホフマン−ラ ロシュ アーゲー |
抗糖尿病化合物としてのベンゾチアゾール、チアゾロピリジン、ベンゾオキサゾール及びオキサゾロピリジン誘導体
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
WO2006104030A1
(ja)
|
2005-03-25 |
2006-10-05 |
Daiichi Sankyo Company, Limited |
チアゾール化合物
|
EP1868991B1
(en)
|
2005-04-01 |
2014-07-30 |
Eli Lilly And Company |
Histamine h3 receptor agents, preparation and therapeutic uses
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
EP1868999B1
(en)
|
2005-04-06 |
2009-07-01 |
F. Hoffmann-Roche AG |
Pyridine-3-carboxamide derivatives as cb1 inverse agonists
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
CA2603757A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
EP1874787B1
(en)
|
2005-04-15 |
2009-12-30 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
CA2605510C
(en)
|
2005-04-19 |
2013-12-24 |
Surface Logix, Inc. |
Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
|
EP1873144B1
(en)
|
2005-04-20 |
2014-07-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
WO2006111849A1
(en)
|
2005-04-20 |
2006-10-26 |
Pfizer Products Inc. |
Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
EP1877067A1
(en)
|
2005-04-26 |
2008-01-16 |
Microbia, Inc. |
4-biarylyl-1-phenylazetidin-2-one glucuronide derivatives for hypercholesterolemia
|
US20090131395A1
(en)
|
2005-05-05 |
2009-05-21 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
JP2008539735A
(ja)
|
2005-05-06 |
2008-11-20 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
グルカゴン様ペプチド1(glp−1)受容体アンタゴニストおよびそれらの薬理学的使用方法
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
BRPI0608970A2
(pt)
|
2005-05-11 |
2010-02-17 |
Microbia Inc |
processos para produção de 4-bifenililazetidin-2-onas fenólicas
|
JP5225074B2
(ja)
|
2005-05-13 |
2013-07-03 |
イーライ リリー アンド カンパニー |
Glp−1peg化化合物
|
JP4975739B2
(ja)
|
2005-05-17 |
2012-07-11 |
シェーリング コーポレイション |
脂質異常症の処置のための、ニコチン酸受容体アゴニストとしての複素環
|
CA2607441C
(en)
|
2005-05-25 |
2013-02-12 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
AU2006249905A1
(en)
|
2005-05-25 |
2006-11-30 |
Microbia, Inc. |
Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
EP1889842A4
(en)
|
2005-06-08 |
2009-07-29 |
Japan Tobacco Inc |
HETEROCYCLIC CONNECTION
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026808A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005026809A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
CA2611142A1
(en)
|
2005-06-15 |
2006-12-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic compounds
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
CA2610903A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
N-(pyridin-2-yl)-sulfonamide derivatives
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
US20080200527A1
(en)
|
2005-06-17 |
2008-08-21 |
Carex Sa |
Cannabinoid Receptor Modulators
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
MY148538A
(en)
|
2005-06-22 |
2013-04-30 |
Astrazeneca Ab |
Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
|
MX2007015779A
(es)
|
2005-06-22 |
2008-02-22 |
Hoffmann La Roche |
(6-fluoro-benzo[1,3]dioxolil)-morfolin-4-il-metanonas y su uso como ligandos cb1.
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
MX2007016545A
(es)
|
2005-06-30 |
2008-02-21 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g.
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
US20100063081A1
(en)
|
2005-06-30 |
2010-03-11 |
Stuart Edward Bradly |
CPCR Agonists
|
UA94052C2
(uk)
|
2005-07-05 |
2011-04-11 |
Ф. Хоффманн-Ля Рош Аг |
Похідні піридазину
|
JP2009500377A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
ジシクロアルキルウレア型グルコキナーゼ活性化剤
|
WO2007007688A1
(ja)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
3,5-ジアミノ-1,2,4-トリアゾール誘導体
|
JP2009500378A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
|
EP2027113A1
(en)
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
NZ575513A
(en)
|
2005-07-09 |
2009-11-27 |
Astrazeneca Ab |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
JP2009500442A
(ja)
|
2005-07-09 |
2009-01-08 |
アストラゼネカ アクチボラグ |
2型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての2−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
|
AR057661A1
(es)
|
2005-07-11 |
2007-12-12 |
Tanabe Seiyaku Co |
Un derivado de oxima y sus preparaciones
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
EP1905769B1
(en)
|
2005-07-13 |
2017-03-29 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
WO2007006814A1
(en)
|
2005-07-14 |
2007-01-18 |
Novo Nordisk A/S |
Urea glucokinase activators
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
EP1757587A1
(en)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
BRPI0613984A2
(pt)
|
2005-07-18 |
2011-03-01 |
Novo Nordisk As |
peptìdios para uso no tratamento da obesidade, seu uso e composição farmacêutica compreendendo os mesmos
|
JP5076159B2
(ja)
|
2005-07-19 |
2012-11-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アセチルコエンザイムaカルボキシラーゼ(acc)阻害薬としてのスピロクロマノン誘導体
|
US8133907B2
(en)
|
2005-07-20 |
2012-03-13 |
Eli Lilly And Company |
Pyridine derivatives as dipeptedyl peptidase inhibitors
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
ES2336603T3
(es)
|
2005-07-21 |
2010-04-14 |
F. Hoffmann-La Roche Ag |
Compuestos de pirido(2,3-d)pirimidina-2,4-diamina como inhibidores de ptp1b.
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
WO2007016460A2
(en)
|
2005-07-29 |
2007-02-08 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction by partial magnetic levitation
|
WO2007013691A1
(ja)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
スピロ環化合物
|
WO2007013689A1
(ja)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
シクロプロパンカルボン酸化合物
|
ES2326357B1
(es)
|
2005-07-29 |
2010-04-21 |
Laboratorios Del Dr. Esteve, S.A. |
Fase amorfa de una pirazolina sustituida, su preparacion y su uso como medicamento.
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
US20080269233A1
(en)
|
2005-08-04 |
2008-10-30 |
Mark David Andrews |
Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
|
CN101282953A
(zh)
|
2005-08-08 |
2008-10-08 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
WO2007018460A1
(en)
|
2005-08-08 |
2007-02-15 |
Astrazeneca Ab |
Therapeutic agents
|
WO2007017649A1
(en)
|
2005-08-09 |
2007-02-15 |
Astrazeneca Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
DE602006018151D1
(de)
|
2005-08-10 |
2010-12-23 |
Glaxosmithkline Llc |
Xanthinderivate als selektive hm74a-agonisten
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
WO2007020213A2
(en)
|
2005-08-18 |
2007-02-22 |
F. Hoffmann-La Roche Ag |
Thiazolyl piperidine derivatives useful as h3 receptor modulators
|
JP2009507791A
(ja)
|
2005-08-29 |
2009-02-26 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法
|
WO2007026215A1
(en)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
WO2007026761A1
(ja)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
チアゾール誘導体
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
MXPA05009633A
(es)
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
GB2429975A
(en)
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
CA2621949A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
EA013084B1
(ru)
|
2005-09-16 |
2010-02-26 |
Арена Фармасьютикалз, Инк. |
Модуляторы метаболизма и лечение связанных с ним нарушений
|
CN101263140A
(zh)
|
2005-09-16 |
2008-09-10 |
阿斯利康(瑞典)有限公司 |
作为葡萄糖激酶活化剂的杂双环化合物
|
CA2623088A1
(en)
|
2005-09-21 |
2007-04-12 |
7Tm Pharma A/S |
Y4 selective receptor agonists for therapeutic interventions
|
CN101268096A
(zh)
|
2005-09-21 |
2008-09-17 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y2选择性受体激动剂
|
US20070066584A1
(en)
|
2005-09-21 |
2007-03-22 |
Wenqing Yao |
Amido compounds and their use as pharmaceuticals
|
US20070117857A1
(en)
|
2005-09-23 |
2007-05-24 |
Fina Liotta |
Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators
|
ES2340201T3
(es)
|
2005-09-23 |
2010-05-31 |
Janssen Pharmaceutica Nv |
Moduladores de hexahidro-ciclooctilpirazol cannabinoides.
|
BRPI0616465A2
(pt)
|
2005-09-29 |
2011-06-21 |
Sanofi Aventis |
derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
|
JP4879988B2
(ja)
|
2005-09-29 |
2012-02-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
メラノコルチン−4受容体モジュレーターとしてのアシル化スピロピペリジン誘導体
|
EP1934256A2
(en)
|
2005-09-30 |
2008-06-25 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
CA2624032A1
(en)
|
2005-09-30 |
2007-04-12 |
Merck & Co., Inc. |
Cholesteryl ester transfer protein inhibitors
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
WO2007041061A2
(en)
|
2005-09-30 |
2007-04-12 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
WO2007037534A1
(ja)
|
2005-09-30 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
2-へテロアリール置換インドール誘導体
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
WO2007047737A1
(en)
|
2005-10-17 |
2007-04-26 |
Acadia Pharmaceuticals Inc. |
Cb-1 modulating compounds and their use
|
DE102005049953A1
(de)
|
2005-10-19 |
2007-04-26 |
Sanofi-Aventis Deutschland Gmbh |
Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
AU2006304434B2
(en)
|
2005-10-20 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
WO2007046548A1
(en)
|
2005-10-21 |
2007-04-26 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
CA2628274A1
(en)
|
2005-11-01 |
2007-05-10 |
Array Biopharma Inc. |
Glucokinase activators
|
EP1960386A2
(en)
|
2005-11-01 |
2008-08-27 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
CN101355938A
(zh)
|
2005-11-01 |
2009-01-28 |
高点制药有限责任公司 |
取代的酰胺的药学应用
|
WO2007051810A2
(en)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma |
Pharmaceutical use of substituted amides
|
JP2009514835A
(ja)
|
2005-11-03 |
2009-04-09 |
プロシディオン・リミテッド |
トリシクロ置換型アミド
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
CA2628486A1
(en)
|
2005-11-03 |
2007-05-10 |
Prosidion Ltd. |
Tricyclo substituted amides
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
JP2007131570A
(ja)
|
2005-11-09 |
2007-05-31 |
Mitsubishi Pharma Corp |
新規なアミノピロリジン誘導体
|
UA95613C2
(ru)
|
2005-11-09 |
2011-08-25 |
Уеллстат Терепьютикс Корпорейшн |
Соединения для лечения расстройсв метаболизма
|
JP4371164B2
(ja)
|
2005-11-10 |
2009-11-25 |
萬有製薬株式会社 |
アザ置換スピロ誘導体
|
US7863329B2
(en)
|
2005-11-17 |
2011-01-04 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
EP1951661B1
(en)
|
2005-11-17 |
2012-08-08 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
JP2009515926A
(ja)
|
2005-11-18 |
2009-04-16 |
エフ.ホフマン−ラ ロシュ アーゲー |
アザインドール−2−カルボキサミド誘導体
|
WO2007057768A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Sulfonyl derivatives
|
GB0523609D0
(en)
|
2005-11-19 |
2005-12-28 |
Vernalis R&D Ltd |
Piperazine derivatives
|
AU2006316087B2
(en)
|
2005-11-21 |
2011-03-10 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I
|
WO2007120270A2
(en)
|
2005-11-22 |
2007-10-25 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
JP5204662B2
(ja)
|
2005-11-22 |
2013-06-05 |
アムジエン・インコーポレーテツド |
11−β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
|
DE102005055726A1
(de)
|
2005-11-23 |
2007-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
ES2339599T3
(es)
|
2005-11-23 |
2010-05-21 |
ELI LILLY & COMPANY |
Antagonistas del receptor de glucagon, preparacion y usos terapeuticos.
|
WO2007060992A1
(ja)
|
2005-11-25 |
2007-05-31 |
Kaneka Corporation |
メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
|
AR058199A1
(es)
|
2005-11-28 |
2008-01-23 |
Merck & Co Inc |
Derivados de 3- alquilazetidina sustituidos con heterociclos
|
WO2007064272A1
(en)
|
2005-11-29 |
2007-06-07 |
Astrazeneca Ab |
Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
|
WO2007063928A1
(ja)
|
2005-11-30 |
2007-06-07 |
Toray Industries, Inc. |
新規な非環状アミンカルボキシアミド誘導体及びその塩
|
PT1959951E
(pt)
|
2005-12-01 |
2010-03-02 |
Hoffmann La Roche |
Derivados de piperidina substituídos com heteroarilo, como inibidores de pct1-f
|
CN1978445B
(zh)
|
2005-12-02 |
2010-09-01 |
中国科学院上海药物研究所 |
一种可用作人源腺苷单核苷酸激活蛋白激酶激活剂的化合物及其制备方法和应用
|
UA94921C2
(en)
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
UA94724C2
(en)
|
2005-12-08 |
2011-06-10 |
Новартис Аг |
Thiadiazolidinone derivatives as antidiabetic agents
|
DE602006010433D1
(de)
|
2005-12-09 |
2009-12-24 |
Hoffmann La Roche |
Für die behandlung von obesitas geeignete tricyclische amidderivate
|
AU2006326540A1
(en)
|
2005-12-14 |
2007-06-21 |
Amgen Inc. |
Diaza heterocyclic sulfonamide derivatives and their uses
|
JP5075129B2
(ja)
|
2005-12-14 |
2012-11-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼ−4阻害剤としての縮合アミノピペリジン
|
CA2633243C
(en)
|
2005-12-15 |
2014-05-27 |
Exelixis, Inc. |
Azepinoindole derivatives as pharmaceutical agents
|
WO2007068620A1
(en)
|
2005-12-15 |
2007-06-21 |
F. Hoffmann-La Roche Ag |
Pyrrolo[2,3-c]pyridine derivatives
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
WO2007068641A1
(en)
|
2005-12-16 |
2007-06-21 |
F. Hoffmann-La Roche Ag |
Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators
|
CA2633803A1
(en)
|
2005-12-19 |
2007-09-07 |
Trustees Of Tufts College |
Soft protease inhibitors and pro-soft forms thereof
|
CA2633584A1
(en)
|
2005-12-20 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
DE602006017259D1
(de)
|
2005-12-21 |
2010-11-11 |
Hoffmann La Roche |
Neues salz und polymorph des dpp-iv-hemmers
|
MX2008008337A
(es)
|
2005-12-21 |
2008-09-03 |
Schering Corp |
Fenoxipiperidinas y sus analogos utiles como antagonistas de histamina h3.
|
CN103224477A
(zh)
|
2005-12-22 |
2013-07-31 |
高点制药有限责任公司 |
作为PPAR-δ活化剂的苯氧基乙酸
|
EP1973885A1
(en)
|
2005-12-22 |
2008-10-01 |
Crystalgenomics, Inc. |
Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
|
CN101384594A
(zh)
|
2005-12-23 |
2009-03-11 |
诺瓦提斯公司 |
用作dpp-iv抑制剂的稠合杂环化合物
|
US20090156465A1
(en)
|
2005-12-30 |
2009-06-18 |
Sattigeri Jitendra A |
Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
CN100999517B
(zh)
|
2006-01-11 |
2010-12-15 |
北京摩力克科技有限公司 |
吡唑甲酰胺衍生物,药物组合物和其制备方法
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
WO2007084319A2
(en)
|
2006-01-13 |
2007-07-26 |
Schering Corporation |
Diaryl piperidines as cb1 modulators
|
CN101374825A
(zh)
|
2006-01-13 |
2009-02-25 |
霍夫曼-拉罗奇有限公司 |
环己基哌嗪基甲酮衍生物及它们作为组胺h3受体调节剂的应用
|
CA2635211A1
(en)
|
2006-01-13 |
2007-08-02 |
Merck & Co., Inc. |
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
MX2008009241A
(es)
|
2006-01-18 |
2008-10-20 |
Evolva Sa |
Moduladores de ppar.
|
CA2637565A1
(en)
|
2006-01-18 |
2007-07-26 |
Schering Corporation |
Cannibinoid receptor modulators
|
WO2007133820A2
(en)
|
2006-01-19 |
2007-11-22 |
Neurogen Corporation |
Diaryl triazolones as cb1 antagonists
|
CA2637766A1
(en)
|
2006-01-20 |
2007-11-08 |
Smithkline Beecham Corporation |
Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
|
EP1984370A4
(en)
|
2006-01-23 |
2010-03-31 |
Crystalgenomics Inc |
PROTEIN KINASE ACTIVITY INHIBITING IMIDAZOPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
|
DE602007008831D1
(de)
|
2006-01-23 |
2010-10-14 |
Hoffmann La Roche |
Cyclohexyl-sulfonamid-derivate mit h3-rezeptoraktivität
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
WO2007087231A2
(en)
|
2006-01-25 |
2007-08-02 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
CN101007804B
(zh)
|
2006-01-25 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
1,3-苯并间二氧杂环戊烯-2,2-二羧酸衍生物、其制备方法和医疗用途
|
CN101437512A
(zh)
|
2006-01-27 |
2009-05-20 |
阿雷生物药品公司 |
葡萄糖激酶活化剂
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
EP1979355B1
(en)
|
2006-01-30 |
2010-08-18 |
Irm Llc |
Spiro imidazole derivatives as ppar modulators
|
ATE445624T1
(de)
|
2006-01-30 |
2009-10-15 |
Irm Llc |
Verbindungen und zusammensetzungen als ppar- modulatoren
|
WO2007086080A2
(en)
|
2006-01-30 |
2007-08-02 |
Glenmark Pharmaceuticals Limited |
NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
AU2007210076A1
(en)
|
2006-01-30 |
2007-08-09 |
Irm Llc |
Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as PPAR modulators
|
EP1979318A1
(en)
|
2006-01-31 |
2008-10-15 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
UY30117A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compuesto amina trisustituido
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
EP1816125A1
(en)
|
2006-02-02 |
2007-08-08 |
Ranbaxy Laboratories, Ltd. |
Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
US7863302B2
(en)
|
2006-02-03 |
2011-01-04 |
Eli Lilly And Company |
Compounds and methods for modulating FX-receptors
|
US7691876B2
(en)
|
2006-02-07 |
2010-04-06 |
Hoffmann-La Roche Inc. |
Heterobicyclic amide compounds
|
US7745477B2
(en)
|
2006-02-07 |
2010-06-29 |
Hoffman-La Roche Inc. |
Heteroaryl and benzyl amide compounds
|
EP2013216A2
(en)
|
2006-02-07 |
2009-01-14 |
AstraZeneca AB |
Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
|
CN101379034B
(zh)
|
2006-02-07 |
2011-12-28 |
弗·哈夫曼-拉罗切有限公司 |
作为cetp抑制剂的苯甲酰胺和杂芳烃衍生物
|
JP2009526058A
(ja)
|
2006-02-07 |
2009-07-16 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、該化合物を含有する組成物及び治療の方法
|
US7678818B2
(en)
|
2006-02-07 |
2010-03-16 |
Hoffmann-La Roche Inc. |
Anthranilamide and 2-amino-heteroarene-carboxamide compounds
|
RU2008132333A
(ru)
|
2006-02-07 |
2010-03-20 |
Вайет (Us) |
Ингибиторы 11-бета hsd1
|
US7572823B2
(en)
|
2006-02-07 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Heteroaryl carboxamide compounds
|
JP5207983B2
(ja)
|
2006-02-09 |
2013-06-12 |
アサーシス, インク. |
肥満および他のcns障害を治療するためのピラゾール類
|
CA2642159A1
(en)
|
2006-02-10 |
2007-08-16 |
Gunderboom, Inc. |
Filter cartridges for fluid intake systems
|
EP1983972A4
(en)
|
2006-02-13 |
2012-01-25 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
|
CN101395170A
(zh)
|
2006-02-14 |
2009-03-25 |
英特塞普特药品公司 |
用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
|
US7795294B2
(en)
|
2006-02-14 |
2010-09-14 |
Janssen Pharmaceutica N.V. |
Tetrahydro-2H-indazole pyrazole cannabinoid modulators
|
DE102006006648A1
(de)
|
2006-02-14 |
2007-08-23 |
Merck Patent Gmbh |
Mandelsäurehydrazide
|
JP2009526868A
(ja)
|
2006-02-15 |
2009-07-23 |
アボット・ラボラトリーズ |
新規なアセチル−CoAカルボキシラーゼ(ACC)阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
|
AU2007216452A1
(en)
|
2006-02-15 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
EP1986652B1
(en)
|
2006-02-15 |
2013-03-20 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
JP5291471B2
(ja)
|
2006-02-15 |
2013-09-18 |
アボット・ラボラトリーズ |
新規なアセチル−CoAカルボキシラーゼ(ACC)阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
|
ITRM20060090A1
(it)
|
2006-02-22 |
2007-08-23 |
Sigma Tau Ind Farmaceuti |
Nuovi composti inibitori cpt a livello del snc come farmaci antidiabetici e o antiobesita
|
WO2007096186A1
(en)
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
SG185849A1
(en)
|
2006-02-23 |
2012-12-28 |
Pfizer Ltd |
Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
|
WO2007100789A2
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
US7728031B2
(en)
|
2006-02-24 |
2010-06-01 |
Abbott Laboratories |
Octahydro-pyrrolo[3,4-b]pyrrole derivatives
|
WO2007100833A2
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
US8268867B2
(en)
|
2006-02-27 |
2012-09-18 |
Cadila Healthcare Limited |
1,3-dioxane carboxylic acids
|
CN101394738A
(zh)
|
2006-02-28 |
2009-03-25 |
维尔斯达医疗公司 |
用于治疗代谢紊乱的化合物
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
JP2007230909A
(ja)
|
2006-03-01 |
2007-09-13 |
Univ Of Tokyo |
置換イソキサゾール誘導体
|
WO2007099385A1
(en)
|
2006-03-01 |
2007-09-07 |
Glenmark Pharmaceuticals S.A. |
Dipeptidyl peptidase iv inhibitor compounds and compositions
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
WO2007101270A1
(en)
|
2006-03-02 |
2007-09-07 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
TW200745099A
(en)
|
2006-03-02 |
2007-12-16 |
Sankyo Co |
Optically active thiazolidinedione derivatives
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
US20090264473A1
(en)
|
2006-03-03 |
2009-10-22 |
Zhiguo Jake Song |
Novel Crystalline Forms of Antidiabetic Compounds
|
US20070270492A1
(en)
|
2006-03-06 |
2007-11-22 |
Avestha Gengraine Technologies Pvt. Ltd. |
Nananoic acid derivatives as dipeptidyl peptidase inhibitors
|
US20080051452A1
(en)
|
2006-03-06 |
2008-02-28 |
Avestha Gengraine Technologies Pvt. Ltd. |
Hexanoic acid derivatives as dipeptidyl peptidase inhibitors
|
TW200800979A
(en)
|
2006-03-07 |
2008-01-01 |
Lundbeck & Co As H |
Halogenated sulfonamide derivatives
|
JP2009132620A
(ja)
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
WO2007104034A2
(en)
|
2006-03-08 |
2007-09-13 |
Takeda San Diego, Inc. |
Glucokinase activators
|
EP1991547A2
(en)
|
2006-03-09 |
2008-11-19 |
Pharmacopeia, Inc. |
8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
|
JP2009529512A
(ja)
|
2006-03-09 |
2009-08-20 |
ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
新規な化合物、それらの製造法、及び使用法
|
KR20080109841A
(ko)
|
2006-03-10 |
2008-12-17 |
뉴로젠 코포레이션 |
피페라지닐 옥소알킬 테트라히드로이소퀴놀린 및 관련유사체
|
WO2007105650A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ajinomoto Co., Inc. |
4-ヒドロキシイソロイシン誘導体および同誘導体の製造方法
|
EP1993560B1
(en)
|
2006-03-10 |
2011-12-28 |
Jenrin Discovery |
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
|
CA2643055A1
(en)
|
2006-03-13 |
2007-09-20 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
WO2007106469A2
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
JP5252435B2
(ja)
|
2006-03-15 |
2013-07-31 |
ノボ・ノルデイスク・エー/エス |
アミリン誘導体
|
EP1834641A1
(en)
|
2006-03-16 |
2007-09-19 |
Sanofi-Aventis |
Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
|
BRPI0708782A2
(pt)
|
2006-03-16 |
2011-06-14 |
Astellas Pharma Inc |
derivado de triazol ou um sal deste
|
JP5243696B2
(ja)
|
2006-03-17 |
2013-07-24 |
田辺三菱製薬株式会社 |
ベンゼン誘導体
|
DE102006012548A1
(de)
|
2006-03-18 |
2007-09-20 |
Bayer Healthcare Ag |
Substituierte Chromanol-Derivate und ihre Verwendung
|
US20100168083A1
(en)
|
2006-03-21 |
2010-07-01 |
Soren Ebdrup |
Adamantane derivatives for the treatment of the metabolic syndrome
|
KR101077366B1
(ko)
|
2006-03-22 |
2011-10-26 |
에프. 호프만-라 로슈 아게 |
11-베타-hsd-1로서의 피라졸
|
US20070238694A1
(en)
|
2006-03-23 |
2007-10-11 |
Inotek Pharmaceuticals Corporation |
Purine compounds and methods of use thereof
|
MX2008012064A
(es)
|
2006-03-23 |
2008-12-17 |
Amgen Inc |
Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas.
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
EP2001472A2
(en)
|
2006-03-23 |
2008-12-17 |
Merck and Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
NZ571997A
(en)
|
2006-03-24 |
2011-08-26 |
Array Biopharma Inc |
2 -aminopyridine analogs as glucokinase activators
|
FR2898894B1
(fr)
|
2006-03-24 |
2008-06-06 |
Genfit Sa |
Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
|
FR2898892A1
(fr)
|
2006-03-24 |
2007-09-28 |
Genfit Sa |
Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
|
US20070254911A1
(en)
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
WO2007112402A1
(en)
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
JP2007291075A
(ja)
|
2006-03-27 |
2007-11-08 |
Sankyo Co Ltd |
新規化合物ステレニン及びその製造方法
|
TW200806669A
(en)
|
2006-03-28 |
2008-02-01 |
Merck & Co Inc |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
CA2645581A1
(en)
|
2006-03-28 |
2007-10-04 |
High Point Pharmaceuticals, Llc |
Benzothiazoles having histamine h3 receptor activity
|
WO2007110237A2
(en)
|
2006-03-28 |
2007-10-04 |
Novartis Ag |
Amide derivatives and their application for the treatment of g protein related diseases
|
DE102006014685A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
|
DE102006014688A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
AU2007245037A1
(en)
|
2006-03-29 |
2007-11-08 |
Merck Sharp & Dohme Corp. |
Diazepan orexin receptor antagonists
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
PT1999132E
(pt)
|
2006-03-30 |
2012-10-02 |
Irm Llc |
Azolopirimidinas como inibidores de atividade do recetor canabinóide 1
|
GB0606429D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
BRPI0710110A2
(pt)
|
2006-03-31 |
2011-08-02 |
Novartis Ag |
compostos orgánicos
|
BRPI0710083A2
(pt)
|
2006-03-31 |
2011-08-02 |
Janssen Pharmaceutica Nv |
entidade quìmica benzoimidazol-2-il pirimidina e pirazina, composição farmacêutica e uso destas
|
BRPI0710182A2
(pt)
|
2006-03-31 |
2012-08-07 |
Novartis Ag |
compostos orgÂnicos.
|
US7851654B2
(en)
|
2006-04-03 |
2010-12-14 |
Industry-Academic Cooperation Foundation Gyeongsang National University |
Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
MX2008012756A
(es)
|
2006-04-03 |
2009-03-05 |
Matrix Lab Ltd |
Inhibidores de dipeptidil peptidasa iv novedosos y procesos para su preparacion y composiciones farmaceuticas que los contienen.
|
CN101050194B
(zh)
|
2006-04-05 |
2013-08-21 |
上海恒瑞医药有限公司 |
双环辛烷类衍生物、其制备方法及其在医药上的用途
|
US20090221639A1
(en)
|
2006-04-06 |
2009-09-03 |
Lisa Sarah Bertram |
Heterocyclic GPCR Agonists
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
CA2651898A1
(en)
|
2006-04-07 |
2007-10-18 |
Develogen Aktiengesellschaft |
Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
|
AU2007236049A1
(en)
|
2006-04-07 |
2007-10-18 |
High Point Pharmaceuticals, Llc |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
EP1842846A1
(en)
|
2006-04-07 |
2007-10-10 |
Santhera Pharmaceuticals (Schweiz) AG |
Phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
US20100029716A1
(en)
|
2006-04-10 |
2010-02-04 |
Concert Pharmaceuticals, Inc. |
Novel 1,2,3,4- tetrahydroquinoline derivatives
|
JP2009533368A
(ja)
|
2006-04-11 |
2009-09-17 |
ノバルティス アクチエンゲゼルシャフト |
有機化合物
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
EP2010512A4
(en)
|
2006-04-11 |
2010-02-24 |
Merck & Co Inc |
NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
|
CN101460453B
(zh)
|
2006-04-11 |
2012-10-03 |
埃科特莱茵药品有限公司 |
磺酰胺化合物
|
JP2009533375A
(ja)
|
2006-04-12 |
2009-09-17 |
エフ.ホフマン−ラ ロシュ アーゲー |
5−アミド−2−カルボキサミドインドール類
|
CN101460491A
(zh)
|
2006-04-12 |
2009-06-17 |
惠氏公司 |
苯胺基嘧啶苯基和苯并噻吩类似物
|
EA200802054A1
(ru)
|
2006-04-12 |
2009-04-28 |
Пробиодруг Аг |
Ингибиторы фермента
|
EP2015769A4
(en)
|
2006-04-13 |
2013-12-25 |
Ipsen Pharma |
PHARMACEUTICAL COMPOSITIONS OF HGLP-1, EXENDINE 4 AND THEIR ANALOGUES
|
US20090281097A1
(en)
|
2006-04-14 |
2009-11-12 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
FR2899899A1
(fr)
|
2006-04-14 |
2007-10-19 |
Sanofi Aventis Sa |
Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique
|
JP2007284090A
(ja)
|
2006-04-14 |
2007-11-01 |
Dic Plastics Inc |
蓋体の係止構造および容器
|
WO2007119837A1
(ja)
|
2006-04-14 |
2007-10-25 |
Ajinomoto Co., Inc. |
リパーゼ阻害剤
|
PE20080188A1
(es)
|
2006-04-18 |
2008-03-10 |
Janssen Pharmaceutica Nv |
Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol
|
RU2435764C2
(ru)
|
2006-04-18 |
2011-12-10 |
Ниппон Кемифар Ко., Лтд. |
АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ
|
WO2007120102A1
(en)
|
2006-04-19 |
2007-10-25 |
Astrazeneca Ab |
New substituted oxindole derivatives
|
MX2008013304A
(es)
|
2006-04-20 |
2008-10-27 |
Amgen Inc |
Compuestos de peptido 1 tipo glucagon.
|
WO2007122970A1
(ja)
|
2006-04-20 |
2007-11-01 |
Osaka University |
核内受容体に結合するリガンド
|
EP2463283B1
(en)
|
2006-04-20 |
2014-06-11 |
Pfizer Products Inc. |
Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
|
GB0607954D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
US20070254952A1
(en)
|
2006-04-21 |
2007-11-01 |
Yuguang Wang |
Cannabinoid receptor modulators
|
GB0607951D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
ES2435115T3
(es)
|
2006-04-21 |
2013-12-18 |
Eli Lilly And Company |
Derivados de bifenilamida-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
|
BRPI0710273A2
(pt)
|
2006-04-21 |
2011-08-09 |
Lilly Co Eli |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, intermediário
|
CA2647677C
(en)
|
2006-04-21 |
2014-03-18 |
Eli Lilly And Company |
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
GB0607953D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
AU2007244960B2
(en)
|
2006-04-24 |
2012-03-01 |
Eli Lilly And Company |
Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
WO2007122634A2
(en)
|
2006-04-24 |
2007-11-01 |
Jubilant Biosys Limited |
Pyrimidinediones as tyrosine kinase inhibitors
|
EA016415B1
(ru)
|
2006-04-24 |
2012-04-30 |
Эли Лилли Энд Компани |
Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1
|
AU2007244955B2
(en)
|
2006-04-24 |
2011-12-08 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
US7659281B2
(en)
|
2006-04-25 |
2010-02-09 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors
|
EP2016071B1
(en)
|
2006-04-25 |
2013-07-24 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
CN101432265B
(zh)
|
2006-04-25 |
2011-12-14 |
伊莱利利公司 |
11-β-羟类固醇脱氢酶1的抑制剂
|
EP2021337B1
(en)
|
2006-04-25 |
2010-01-13 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
ATE496051T1
(de)
|
2006-04-26 |
2011-02-15 |
Actelion Pharmaceuticals Ltd |
Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
|
WO2007121687A1
(fr)
|
2006-04-26 |
2007-11-01 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China |
Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments
|
WO2007122411A1
(en)
|
2006-04-26 |
2007-11-01 |
Astrazeneca Ab |
Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
|
TW200811098A
(en)
|
2006-04-27 |
2008-03-01 |
Astrazeneca Ab |
Chemical compounds
|
WO2007126043A1
(ja)
|
2006-04-27 |
2007-11-08 |
Mitsubishi Tanabe Pharma Corporation |
チアゾール環を含むカルボン酸誘導体の医薬用途
|
US20070254863A1
(en)
|
2006-04-27 |
2007-11-01 |
Jochen Antel |
Use of CBx cannabinoid receptor modulators as potassium channel modulators
|
ES2354917T3
(es)
|
2006-04-28 |
2011-03-21 |
Transtech Pharma, Inc. |
Activadores de la benzamidaglucoquinasa.
|
US7829582B2
(en)
|
2006-04-28 |
2010-11-09 |
Eli Lilly And Company |
Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
WO2007125952A1
(ja)
|
2006-04-28 |
2007-11-08 |
Shionogi & Co., Ltd. |
Npy y5受容体拮抗作用を有するアミン誘導体
|
EP1849785A1
(en)
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
EP2019824A2
(en)
|
2006-04-28 |
2009-02-04 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
US20070293529A1
(en)
|
2006-05-01 |
2007-12-20 |
Yun-Long Li |
Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
|
JP2009167103A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
ピラゾリル5−チオグリコシド化合物
|
JP2009167104A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
フェニル5−チオグリコシド化合物
|
EP1854806A1
(en)
|
2006-05-02 |
2007-11-14 |
MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Thioglycosides as pharmaceutically active agents
|
CN101437823B
(zh)
|
2006-05-04 |
2014-12-10 |
勃林格殷格翰国际有限公司 |
多晶型
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
JP5561720B2
(ja)
|
2006-05-05 |
2014-07-30 |
ジェンリン ディスカバリー |
肥満及び糖尿病を含む心臓血管障害を治療するために有用なカンナビノイド受容体アンタゴニスト/インバ−スアゴニスト
|
US20090326041A1
(en)
|
2006-05-05 |
2009-12-31 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of sglt2
|
WO2007128801A1
(en)
|
2006-05-08 |
2007-11-15 |
Novartis Ag |
Combination of organic compounds
|
US20080247964A1
(en)
|
2006-05-08 |
2008-10-09 |
Yuelian Xu |
Substituted azaspiro derivatives
|
JP5269767B2
(ja)
|
2006-05-09 |
2013-08-21 |
ノボ・ノルデイスク・エー/エス |
インスリン誘導体
|
ES2553154T3
(es)
|
2006-05-09 |
2015-12-04 |
Novo Nordisk A/S |
Derivado de la insulina
|
US8232403B2
(en)
|
2006-05-10 |
2012-07-31 |
Novartis Ag |
Bicyclic derivatives as CETP inhibitors
|
EP2024272A4
(en)
|
2006-05-10 |
2010-11-17 |
Renovis Inc |
AMID DERIVATIVES AS ION CHANNEL NIGANDS, AND PHARMACEUTICAL COMPOSITIONS AND USER METHOD THEREFOR
|
WO2007129188A1
(en)
|
2006-05-10 |
2007-11-15 |
Pfizer Japan Inc. |
Cyclopropanecarboxamide compound
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
KR20090018946A
(ko)
|
2006-05-11 |
2009-02-24 |
노파르티스 아게 |
Cetp 억제제로서의 벤질아민 유도체
|
WO2007134149A2
(en)
|
2006-05-11 |
2007-11-22 |
Janssen Pharmaceutica N.V. |
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2008079427A1
(en)
|
2006-05-11 |
2008-07-03 |
Janssen Pharmaceutica N.V. |
1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors
|
EP2024338B1
(de)
|
2006-05-11 |
2009-09-02 |
Sanofi-Aventis |
4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
US7851468B2
(en)
|
2006-05-15 |
2010-12-14 |
Cephalon, Inc. |
Substituted pyrazolo[3,4-d]pyrimidines
|
CA2651777A1
(en)
|
2006-05-15 |
2007-11-29 |
Merck & Co., Inc. |
Pro-drugs of tertiary alcohols
|
JP5271895B2
(ja)
|
2006-05-15 |
2013-08-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
抗糖尿病性の二環式化合物
|
WO2007133756A2
(en)
|
2006-05-15 |
2007-11-22 |
Neurogen Corporation |
Crf1 receptor ligands comprising heteroaryl fused bicycles
|
WO2007136577A2
(en)
|
2006-05-16 |
2007-11-29 |
Merck & Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
US7812027B2
(en)
|
2006-05-16 |
2010-10-12 |
Merck Sharp & Dohme Corp. |
Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
US7432255B2
(en)
|
2006-05-16 |
2008-10-07 |
Hoffmann-La Roche Inc. |
1H-indol-5-yl-piperazin-1-yl-methanone derivatives
|
CA2652375A1
(en)
|
2006-05-17 |
2007-11-29 |
Incyte Corporation |
Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
|
AU2007253485B2
(en)
|
2006-05-18 |
2010-07-08 |
F. Hoffmann-La Roche Ag |
Thiazolo-pyramidine / pyridine urea derivatives as adenosine A2B receptor antagonists
|
EP2019673A4
(en)
|
2006-05-18 |
2010-06-16 |
Wellstat Therapeutics Corp |
COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
|
WO2007136607A2
(en)
|
2006-05-18 |
2007-11-29 |
Merck & Co., Inc. |
Substituted esters as cannabinoid-1 receptor modulators
|
NZ573687A
(en)
|
2006-05-19 |
2010-10-29 |
Taisho Pharmaceutical Co Ltd |
C-phenyl glycitol compound for the treatment of diabetes
|
PE20080371A1
(es)
|
2006-05-19 |
2008-04-09 |
Wyeth Corp |
N-benzoil-y-n-bencilpirrolidin-3-ilaminas como antagonistas de histamina-3
|
CA2653062A1
(en)
|
2006-05-23 |
2007-11-29 |
Transtech Pharma, Inc. |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
|
AU2007253513B2
(en)
|
2006-05-23 |
2010-07-08 |
F. Hoffmann-La Roche Ag |
Pyridopyrimidinone derivatives
|
WO2007135427A1
(en)
|
2006-05-23 |
2007-11-29 |
Astrazeneca Ab |
1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
|
EP2019679B1
(en)
|
2006-05-23 |
2018-06-20 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
EP2029558B1
(en)
|
2006-05-24 |
2010-03-10 |
Eli Lilly And Company |
Compounds and methods for modulating fxr
|
MX2008014854A
(es)
|
2006-05-24 |
2008-12-05 |
Lilly Co Eli |
Antagonistas de fxr.
|
JP5105297B2
(ja)
|
2006-05-25 |
2012-12-26 |
味の素株式会社 |
Ppar活性調節剤
|
WO2007139992A2
(en)
|
2006-05-26 |
2007-12-06 |
Novartis Ag |
ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS
|
TW200806625A
(en)
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
WO2007140005A2
(en)
|
2006-05-26 |
2007-12-06 |
Janssen Pharmaceutica N.V. |
Oxazolyl piperidine modulators of fatty acid amide hydrolase
|
RU2442602C2
(ru)
|
2006-05-26 |
2012-02-20 |
Нестек С.А. |
Питательные композиции на основе экстракта тоути и способы их применения
|
PT2079732E
(pt)
|
2006-05-29 |
2012-02-02 |
High Point Pharmaceuticals Llc |
3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)- piridazina, os seus sais e solvatos e a sua utilização a título de antagonista do receptor h3 de histamina
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
EP2032536B1
(en)
|
2006-05-30 |
2015-05-06 |
Janssen Pharmaceutica N.V. |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
BRPI0711740A2
(pt)
|
2006-05-30 |
2011-12-06 |
Hoffmann La Roche |
compostos, processo para a sua manufatura,composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, método para o tratamento ou prevenção de obesidade, de diabetes do tipo ii, e uso dos compostos na manufatura de medicamentos
|
JP2009538933A
(ja)
|
2006-05-31 |
2009-11-12 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての化合物およびその使用
|
BRPI0712720A2
(pt)
|
2006-05-31 |
2012-11-20 |
Abbott Lab |
compostos tiazàis como ligantes do receptor canabinàide e usos dos mesmos
|
US8008332B2
(en)
|
2006-05-31 |
2011-08-30 |
Takeda San Diego, Inc. |
Substituted indazoles as glucokinase activators
|
WO2007138050A1
(en)
|
2006-05-31 |
2007-12-06 |
Solvay Pharmaceuticals B.V. |
Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
|
WO2007137962A1
(en)
|
2006-06-01 |
2007-12-06 |
F. Hoffmann-La Roche Ag |
Thiazole derivatives
|
WO2007143164A1
(en)
|
2006-06-02 |
2007-12-13 |
San Diego State University Research Foundation |
Compositions and methods for ameliorating hyperlipidemia
|
JP2009190971A
(ja)
|
2006-06-06 |
2009-08-27 |
Mitsubishi Tanabe Pharma Corp |
2−シアノピロリジン誘導体
|
FR2901792A1
(fr)
|
2006-06-06 |
2007-12-07 |
Negma Lerads Soc Par Actions S |
DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
|
ATE476418T1
(de)
|
2006-06-08 |
2010-08-15 |
Amgen Inc |
Benzamidderivate und assoziierte verwendungen
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
US20070287674A1
(en)
|
2006-06-08 |
2007-12-13 |
Hej Research Institute Of Chemistry |
New treatment of diabetes mellitus
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
EP2035373B1
(en)
|
2006-06-09 |
2011-05-04 |
Action Pharma A/S |
Phenyl pyrrole aminoguanidine derivatives
|
WO2007146761A2
(en)
|
2006-06-12 |
2007-12-21 |
Neurogen Corporation |
Diaryl pyrimidinones and related compounds
|
WO2008035359A2
(en)
|
2006-06-12 |
2008-03-27 |
Cadila Healthcare Limited |
Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
|
WO2007144394A2
(en)
|
2006-06-16 |
2007-12-21 |
High Point Pharmaceuticals, Llc. |
Pharmaceutical use of substituted piperidine carboxamides
|
US20100048714A1
(en)
|
2006-06-19 |
2010-02-25 |
University Of Utah Research Foundation |
Methods and Compositions Related to Inhibition of Ceramide Synthesis
|
US7629346B2
(en)
|
2006-06-19 |
2009-12-08 |
Hoffmann-La Roche Inc. |
Pyrazinecarboxamide derivatives as CB1 antagonists
|
CN101472896A
(zh)
|
2006-06-20 |
2009-07-01 |
阿斯利康(瑞典)有限公司 |
治疗药剂
|
CN101472897A
(zh)
|
2006-06-20 |
2009-07-01 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
WO2008001160A1
(en)
|
2006-06-23 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
CN101466714B
(zh)
|
2006-06-23 |
2013-02-06 |
英赛特股份有限公司 |
作为hm74a激动剂的嘌呤酮衍生物
|
AR061626A1
(es)
|
2006-06-23 |
2008-09-10 |
Incyte Corp |
Derivados de purinona como agonistas de hm74a
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
WO2008002575A1
(en)
|
2006-06-26 |
2008-01-03 |
The Procter & Gamble Company |
Melanin concentrating hormone antagonists
|
CN101096363B
(zh)
|
2006-06-27 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
|
TW200815418A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds I
|
TW200815417A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds II
|
CA2656320C
(en)
|
2006-06-27 |
2015-04-28 |
Intercept Pharmaceuticals, Inc. |
Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
|
PE20080344A1
(es)
|
2006-06-27 |
2008-06-09 |
Sanofi Aventis |
Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1
|
PE20080212A1
(es)
|
2006-06-27 |
2008-04-25 |
Sanofi Aventis |
Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1)
|
AU2007265966B2
(en)
|
2006-06-27 |
2012-05-17 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
US20080004281A1
(en)
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
US20080004325A1
(en)
|
2006-06-29 |
2008-01-03 |
Wyeth |
PTP1B inhibitors
|
AU2007265239A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Butyl and butynyl benzyl amine compounds
|
AU2007265238A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted benzamide modulators of the histamine H3 receptor
|
AU2007265242A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted benzyl amine compounds
|
RU2434862C2
(ru)
|
2006-06-29 |
2011-11-27 |
Тайсо Фармасьютикал Ко., Лтд. |
С-фенил-1-тиоглюцитолы
|
AU2007263807B2
(en)
|
2006-06-29 |
2011-06-02 |
F. Hoffmann-La Roche Ag |
Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
|
AU2007265240A1
(en)
|
2006-06-29 |
2008-01-03 |
Janssen Pharmaceutica N.V. |
Substituted aminomethyl benzamide compounds
|
JP2009542673A
(ja)
|
2006-06-29 |
2009-12-03 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
ヒスタミンh3−受容体関連障害の治療に有用なヒスタミンh3−受容体モジュレータ
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
CA2655692C
(en)
|
2006-07-05 |
2012-01-03 |
F. Hoffmann-La Roche Ag |
Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1)
|
DE102006031176A1
(de)
|
2006-07-06 |
2008-01-10 |
Bayer Healthcare Ag |
Substituierte Benzoxepino-isoxazole und ihre Verwendung
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
JP5194588B2
(ja)
|
2006-07-06 |
2013-05-08 |
大正製薬株式会社 |
1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
|
US7888504B2
(en)
|
2006-07-06 |
2011-02-15 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
EP2046753A2
(en)
|
2006-07-06 |
2009-04-15 |
Brystol-Myers Squibb Company |
Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
US7803799B2
(en)
|
2006-07-07 |
2010-09-28 |
National Health Research Institutes |
Selenophene compounds
|
US7795291B2
(en)
|
2006-07-07 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
|
CN101100458A
(zh)
|
2006-07-07 |
2008-01-09 |
上海艾力斯医药科技有限公司 |
具有PPARγ激动剂活性的双苯并咪唑衍生物及其应用
|
US20080009534A1
(en)
|
2006-07-07 |
2008-01-10 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
FR2903404B1
(fr)
|
2006-07-10 |
2008-08-22 |
Servier Lab |
Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2008007211A1
(en)
|
2006-07-11 |
2008-01-17 |
Pfizer Japan Inc. |
Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
|
US7297710B1
(en)
|
2006-07-12 |
2007-11-20 |
Sanofi-Aventis |
Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide, their preparation and their application in therapeutics
|
US8048908B2
(en)
|
2006-07-13 |
2011-11-01 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
EP1878721A1
(en)
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
KR20090031898A
(ko)
|
2006-07-13 |
2009-03-30 |
교와 핫꼬 기린 가부시키가이샤 |
펜타디엔아미드 유도체
|
WO2008008895A1
(en)
|
2006-07-13 |
2008-01-17 |
Smithkline Beecham Corporation |
Gpr119 agonists for the treatment of diabetes and related disorders
|
US20100029736A1
(en)
|
2006-07-14 |
2010-02-04 |
Merck & Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
WO2008008547A2
(en)
|
2006-07-14 |
2008-01-17 |
Ams Research Corporation |
Balloon dilation for implantable prosthesis
|
JP5372318B2
(ja)
|
2006-07-14 |
2013-12-18 |
パナソニック株式会社 |
電気化学キャパシタの製造方法
|
US8618102B2
(en)
|
2006-07-14 |
2013-12-31 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
EP2049529B1
(en)
|
2006-07-14 |
2010-08-11 |
Merck Sharp & Dohme Corp. |
Substituted diazepan orexin receptor antagonists
|
TWI332501B
(en)
|
2006-07-14 |
2010-11-01 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
WO2008010061A2
(en)
|
2006-07-17 |
2008-01-24 |
Glenmark Pharmaceuticals S.A. |
3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
BRPI0714828A2
(pt)
|
2006-07-17 |
2013-04-09 |
Novartis Ag |
amidas de Ácido colÂnico
|
DE102006033140A1
(de)
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
CA2657258A1
(en)
|
2006-07-20 |
2008-01-24 |
Novartis Ag |
Amino-piperidine derivatives as cetp inhibitors
|
US7666888B2
(en)
|
2006-07-20 |
2010-02-23 |
Amgen Inc. |
Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1
|
AU2007274598A1
(en)
|
2006-07-21 |
2008-01-24 |
Lupin Limited |
Antidiabetic azabicyclo [3. 1. 0] hexan compounds
|
FR2903984B1
(fr)
|
2006-07-24 |
2008-10-03 |
Genfit Sa |
Derives d'imidazolones substitues, preparation et utilisations
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
TWI403516B
(zh)
|
2006-07-27 |
2013-08-01 |
Chugai Pharmaceutical Co Ltd |
To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
TWI432446B
(zh)
|
2006-07-27 |
2014-04-01 |
Chugai Pharmaceutical Co Ltd |
稠環螺酮縮醇衍生物、及其做為糖尿病治療藥之使用
|
EP2049548A1
(en)
|
2006-07-27 |
2009-04-22 |
UCB Pharma, S.A. |
Fused oxazoles & thiazoles as histamine h3- receptor ligands
|
US20100022589A1
(en)
|
2006-07-27 |
2010-01-28 |
Mccoull William |
Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
|
US20080027014A1
(en)
|
2006-07-28 |
2008-01-31 |
Tanabe Seiyaku Co., Ltd. |
Novel SGLT inhibitors
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
US20090312286A1
(en)
|
2006-08-02 |
2009-12-17 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
|
WO2008016730A2
(en)
|
2006-08-02 |
2008-02-07 |
Targeted Molecular Diagnostics, Llc |
Compositions and methods for reducing cellular fat
|
WO2008016175A1
(fr)
|
2006-08-03 |
2008-02-07 |
Nippon Chemiphar Co., Ltd. |
Agent activant de récepteur activé par les proliférateurs des peroxysomes
|
CN101522623B
(zh)
|
2006-08-03 |
2013-06-12 |
塔夫茨大学信托人 |
无潮红烟酸类似物和其使用方法
|
US7514433B2
(en)
|
2006-08-03 |
2009-04-07 |
Hoffmann-La Roche Inc. |
1H-indole-6-yl-piperazin-1-yl-methanone derivatives
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
EP2058309A4
(en)
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
KR100826108B1
(ko)
|
2006-08-04 |
2008-04-29 |
한국화학연구원 |
퓨란-2-카복실산 유도체 및 그의 제조 방법
|
WO2008019309A1
(en)
|
2006-08-04 |
2008-02-14 |
Metabasis Therapeutics, Inc. |
Novel inhibitors of fructose 1,6-bisphosphatase
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
EP2610244A1
(en)
|
2006-08-07 |
2013-07-03 |
Ironwood Pharmaceuticals, Inc. |
Indole compounds
|
EP1887006A1
(en)
|
2006-08-07 |
2008-02-13 |
Krka |
Polymorphic forms of rosiglitazone base
|
BRPI0715160A2
(pt)
|
2006-08-08 |
2013-06-11 |
Sanofi Aventis |
imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
|
US8071583B2
(en)
|
2006-08-08 |
2011-12-06 |
Boehringer Ingelheim International Gmbh |
Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus
|
WO2008021851A2
(en)
|
2006-08-09 |
2008-02-21 |
Smithkline Beecham Corporation |
Novel compounds as antagonists or inverse agonists for opioid receptors
|
JP5362565B2
(ja)
|
2006-08-09 |
2013-12-11 |
スミスクライン ビーチャム コーポレーション |
オピオイド受容体のアンタゴニストまたはインバースアゴニストである新規化合物
|
TWI433839B
(zh)
|
2006-08-11 |
2014-04-11 |
Neomed Inst |
新穎的苯并咪唑衍生物290
|
WO2008017852A1
(en)
|
2006-08-11 |
2008-02-14 |
Palatin Technologies, Inc. |
Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators
|
WO2008022015A2
(en)
|
2006-08-11 |
2008-02-21 |
Trustees Of Tufts College |
Retro-inverso incretin analogues, and methods of use thereof
|
US7750019B2
(en)
|
2006-08-11 |
2010-07-06 |
Kowa Company, Ltd. |
Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
|
WO2008020405A2
(en)
|
2006-08-15 |
2008-02-21 |
Actelion Pharmaceuticals Ltd |
Azetidine compounds as orexin receptor antagonists
|
WO2008020011A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
CA2660835A1
(en)
|
2006-08-17 |
2008-02-21 |
Amylin Pharmaceuticals, Inc. |
Dpp-iv resistant gip hybrid polypeptides with selectable propperties
|
JP2009256208A
(ja)
|
2006-08-17 |
2009-11-05 |
Dainippon Sumitomo Pharma Co Ltd |
フタリド誘導体またはその薬学的に許容される塩
|
CA2661085A1
(en)
|
2006-08-18 |
2008-02-21 |
N.V. Organon |
Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
|
EP2056828A4
(en)
|
2006-08-21 |
2010-06-23 |
Merck Sharp & Dohme |
SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS
|
ZA200901163B
(en)
|
2006-08-23 |
2010-08-25 |
Neurogen Corp |
2-Phenoxy pyrimidinone analogues
|
JP2010501540A
(ja)
|
2006-08-23 |
2010-01-21 |
ファイザー・プロダクツ・インク |
Gsk−3阻害剤としてのピリミドン化合物
|
CN101563349A
(zh)
|
2006-08-23 |
2009-10-21 |
神经能质公司 |
经卤烷基取代的嘧啶酮衍生物
|
WO2008023720A1
(fr)
|
2006-08-23 |
2008-02-28 |
Astellas Pharma Inc. |
COMPOSÉ D'URÉE OU SEL DUDIT COMPOSé
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2008024497A2
(en)
|
2006-08-25 |
2008-02-28 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
CN101511833A
(zh)
|
2006-08-28 |
2009-08-19 |
埃科特莱茵药品有限公司 |
1,4,5,6,7,8-六氢-1,2,5-三氮杂-甘菊环烃衍生物
|
EP1894928A1
(en)
|
2006-08-29 |
2008-03-05 |
PheneX Pharmaceuticals AG |
Heterocyclic fxr binding compounds
|
WO2008029217A2
(en)
|
2006-08-29 |
2008-03-13 |
Orchid Research Laboratories Limited |
Dipeptidyl peptidase iv inhibitors
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
JP2010501629A
(ja)
|
2006-08-30 |
2010-01-21 |
ビオヴィトルム・アクチボラゲット(プブリクト) |
Gpr119関連障害を治療するためのピリジン化合物
|
US8344180B2
(en)
|
2006-08-30 |
2013-01-01 |
Shionogi & Co., Ltd. |
Hydrazine amide derivative
|
JP5207382B2
(ja)
|
2006-08-30 |
2013-06-12 |
塩野義製薬株式会社 |
ウレア誘導体
|
CL2007002499A1
(es)
|
2006-08-30 |
2008-03-14 |
Phenomix Corp |
Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes.
|
US7470697B2
(en)
|
2006-09-01 |
2008-12-30 |
Adenosine Therapeutics, Llc |
Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptors
|
NZ575346A
(en)
|
2006-09-01 |
2012-02-24 |
Vertex Pharma |
5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
|
WO2008028188A2
(en)
|
2006-09-01 |
2008-03-06 |
The Ticket Reserve |
Demand aggregation for future items contingent upon threshold demand
|
CA2661404A1
(en)
|
2006-09-05 |
2008-03-13 |
Schering Corporation |
Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
|
JP2008063256A
(ja)
|
2006-09-06 |
2008-03-21 |
Astellas Pharma Inc |
β‐アミノ酸誘導体
|
AU2007293028B2
(en)
|
2006-09-07 |
2012-05-31 |
Amgen Inc. |
Heterocyclic GPR40 modulators
|
WO2008030618A1
(en)
|
2006-09-07 |
2008-03-13 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
WO2008028662A1
(en)
|
2006-09-07 |
2008-03-13 |
Santhera Pharmaceuticals (Schweiz) Ag |
N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus
|
US20080096799A1
(en)
|
2006-09-07 |
2008-04-24 |
Forbes Medi-Tech (Research), Inc. |
Compounds for and methods of treating insulin resistance and inflammation
|
JP2010502688A
(ja)
|
2006-09-08 |
2010-01-28 |
ファイザー・プロダクツ・インク |
ジアリールエーテル誘導体およびその使用
|
EP2068862A2
(en)
|
2006-09-08 |
2009-06-17 |
The Scripps Research Institute |
Substituted oxazole ketone modulators of fatty acid amide hydrolase
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
KR100886466B1
(ko)
|
2006-09-12 |
2009-03-04 |
(주)한국씨엔에스팜 |
신규한 스티그마스테롤 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법, 및 이를 포함하는 비만억제 또는 고지혈증 예방 및 치료용 조성물
|
JP2010503654A
(ja)
|
2006-09-12 |
2010-02-04 |
ファイザー・プロダクツ・インク |
ベンゾイミダゾロン誘導体
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
WO2008033931A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
|
WO2008033934A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
|
SI2073810T1
(sl)
|
2006-09-13 |
2011-12-30 |
Takeda Pharmaceutical |
Uporaba 2-6(3-amino-piperidin-1-il)-3-metil-2,4-diokso-3,4-dihidro-2H-pirimidin -1-ilmetil-4-fluoro-benzonitrila za zdravljenje diabetesa, raka, avtoimunskih motenj in infekcije s HIV
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
US7781593B2
(en)
|
2006-09-14 |
2010-08-24 |
Hoffmann-La Roche Inc. |
5-phenyl-nicotinamide derivatives
|
US20100016274A1
(en)
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
US20080076750A1
(en)
|
2006-09-15 |
2008-03-27 |
Aslanian Robert G |
Azetidinone Derivatives and Methods of Use Thereof
|
DE602007008742D1
(de)
|
2006-09-15 |
2010-10-07 |
Pfizer |
Substituierte pyridylmethylbicyclocarboxyamidverbindungen
|
CN101528746A
(zh)
|
2006-09-15 |
2009-09-09 |
先灵公司 |
治疗脂质代谢障碍、疼痛、糖尿病和其它障碍的螺环氮杂环丁酮衍生物
|
CA2663502A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Azetidinone derivatives and methods of use thereof
|
KR101088196B1
(ko)
|
2006-09-20 |
2011-11-30 |
일라이 릴리 앤드 캄파니 |
티오펜 피라졸로피리미딘 화합물
|
WO2008036021A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands
|
WO2008036022A1
(en)
|
2006-09-20 |
2008-03-27 |
Astrazeneca Ab |
Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands
|
CA2663511C
(en)
|
2006-09-20 |
2012-12-04 |
Eli Lilly And Company |
Thiazole pyrazolopyrimidines as crf1 receptor antagonists
|
WO2008035356A2
(en)
|
2006-09-20 |
2008-03-27 |
Glenmark Pharmaceuticals Limited |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
US7858587B2
(en)
|
2006-09-21 |
2010-12-28 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
|
PL2074141T3
(pl)
|
2006-09-22 |
2017-02-28 |
Novo Nordisk A/S |
Analogi insuliny oporne na proteazę
|
WO2008039418A2
(en)
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor modulators
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
|
TW200823227A
(en)
|
2006-09-29 |
2008-06-01 |
Actelion Pharmaceuticals Ltd |
3-aza-bicyclo[3.1.0]hexane derivatives
|
CN101528740B
(zh)
|
2006-09-29 |
2012-09-19 |
株式会社绿十字 |
作为大麻素cb1受体拮抗剂的杂芳基-吡唑衍生物
|
EP2081889B1
(en)
|
2006-09-29 |
2010-12-22 |
F. Hoffmann-La Roche AG |
Sulfonamide derivatives
|
WO2008039882A1
(en)
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
CN101522626A
(zh)
|
2006-10-04 |
2009-09-02 |
霍夫曼-拉罗奇有限公司 |
作为hdl-胆固醇升高剂的3-吡啶甲酰胺或2-吡嗪甲酰胺衍生物
|
AR063028A1
(es)
|
2006-10-06 |
2008-12-23 |
Banyu Pharma Co Ltd |
Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
|
WO2008044656A1
(fr)
|
2006-10-06 |
2008-04-17 |
Taisho Pharmaceutical Co., Ltd. |
Dérivé d'imidazolidinone
|
PE20081152A1
(es)
|
2006-10-06 |
2008-08-10 |
Wyeth Corp |
Azaciclilaminas n-sustituidas como antagonistas de histamina-3
|
GB0619860D0
(en)
|
2006-10-06 |
2006-11-15 |
Birkeland Innovasjon As |
Treatment of insulin resistance and disorders associated therewith
|
WO2008040974A1
(en)
|
2006-10-07 |
2008-04-10 |
Peakdale Molecular Limited |
Indoles for use as dpp-iv inhibitors
|
US8022061B2
(en)
|
2006-10-10 |
2011-09-20 |
Amgen Inc. |
N-aryl pyrazole compounds, compositions, and methods for their use
|
EP1911747A1
(en)
|
2006-10-11 |
2008-04-16 |
Laboratorios del Dr. Esteve S.A. |
Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
|
WO2008044700A1
(fr)
|
2006-10-11 |
2008-04-17 |
Takeda Pharmaceutical Company Limited |
INHIBITEUR DE LA GSK-3β
|
WO2008046071A2
(en)
|
2006-10-12 |
2008-04-17 |
Transition Therapeutics Inc. |
Compounds and methods of treating metabolic syndrome and inflammation
|
WO2008044762A1
(fr)
|
2006-10-13 |
2008-04-17 |
Chugai Seiyaku Kabushiki Kaisha |
Dérivé de spirocétal de thioglucose et utilisation de celui-ci comme agent thérapeutique pour le diabète
|
US20080107725A1
(en)
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
WO2008044111A1
(en)
|
2006-10-13 |
2008-04-17 |
Pfizer Products Inc. |
Pharmaceutical formulation tablet
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
DE102006048728A1
(de)
|
2006-10-16 |
2008-04-17 |
Merck Patent Gmbh |
3-Amino-imidazo{1,2-a]pyridinderivate
|
CN106982382B
(zh)
|
2006-10-16 |
2020-10-16 |
维德约股份有限公司 |
用于在可分级视频编码中信令并执行时间级切换的系统和方法
|
WO2008048648A2
(en)
|
2006-10-17 |
2008-04-24 |
Acadia Pharmaceuticals Inc. |
Cb1-modulating compounds and their use
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
CA2666489C
(en)
|
2006-10-19 |
2012-10-02 |
F. Hoffmann-La Roche Ag |
Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
|
NZ576570A
(en)
|
2006-10-19 |
2010-11-26 |
Takeda Pharmaceutical |
7-sulfonylamino-2-thiazol and 2-thiadiazol -indole compounds
|
JP2010507587A
(ja)
|
2006-10-20 |
2010-03-11 |
アレテ セラピューティクス, インコーポレイテッド |
可溶性エポキシドヒドロラーゼ阻害剤
|
US20100204278A1
(en)
|
2006-10-20 |
2010-08-12 |
Beresis Richard T |
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
|
EP2079695A2
(en)
|
2006-10-20 |
2009-07-22 |
Arete Therapeutics, INC. |
Phenylurea compounds as soluble epoxide hydrolase inhibitors
|
KR100812538B1
(ko)
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
WO2008050199A2
(en)
|
2006-10-23 |
2008-05-02 |
Pfizer Japan Inc. |
Substituted phenylmethyl bicyclocarboxyamide compounds
|
TW200825063A
(en)
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
JO2653B1
(en)
|
2006-10-24 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Tetrahydroflavin 1-carboxylic acid substituted with pyridine or pyrazine inhibit MTB
|
CA2664143C
(en)
|
2006-10-24 |
2015-12-01 |
Janssen Pharmaceutica Nv |
Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
|
SA07280576B1
(ar)
|
2006-10-26 |
2011-06-22 |
استرازينيكا ايه بي |
مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
|
US20080103201A1
(en)
|
2006-10-26 |
2008-05-01 |
Wijayabandara Mirihanage Don J |
Novel alpha-Glucosidase inhibitor from Tabernaemontana dichotoma
|
WO2008049711A1
(en)
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
EP2086991A1
(en)
|
2006-10-27 |
2009-08-12 |
Boehringer Ingelheim International GmbH |
CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
JP2010508268A
(ja)
|
2006-10-31 |
2010-03-18 |
メルク エンド カムパニー インコーポレーテッド |
抗糖尿病二環式化合物
|
EP2089389A2
(en)
|
2006-11-01 |
2009-08-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity
|
WO2008057859A2
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-i and/or nf-kappab activity and use thereof
|
JP2010508358A
(ja)
|
2006-11-01 |
2010-03-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
|
CA2667211A1
(en)
|
2006-11-01 |
2008-05-08 |
Pronova Biopharma Norge As |
Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar)
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
EP2094692B1
(en)
|
2006-11-01 |
2012-11-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
|
US7968577B2
(en)
|
2006-11-01 |
2011-06-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
JP2010509216A
(ja)
|
2006-11-02 |
2010-03-25 |
メルク エンド カムパニー インコーポレーテッド |
ヘテロシクリル置換抗高コレステロール血症化合物
|
US8263587B2
(en)
|
2006-11-02 |
2012-09-11 |
Piramal Healthcare Limited |
Benzoxazepine compounds, their preparation and use
|
EP1918281A1
(en)
|
2006-11-02 |
2008-05-07 |
Laboratorios del Dr. Esteve S.A. |
Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
|
CA2668429A1
(en)
|
2006-11-02 |
2008-05-15 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
WO2008052658A1
(de)
|
2006-11-02 |
2008-05-08 |
Sanofi-Aventis Deutschland Gmbh |
Neues mit piperazin-1-sulfonsäure substituiertes diphenylazetidinon mit verbesserten pharmakologischen eigenschaften
|
AU2007315848A1
(en)
|
2006-11-03 |
2008-05-08 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
TW200827346A
(en)
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1918285A1
(en)
|
2006-11-03 |
2008-05-07 |
Merck Sante |
Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
|
WO2008056377A2
(en)
|
2006-11-06 |
2008-05-15 |
Cadila Healthcare Limited |
Polymorphic forms of rimonabant
|
JP2010508371A
(ja)
|
2006-11-06 |
2010-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換フェニル誘導体、該化合物を含有する医薬品及びその使用と製造方法
|
EP1921080B1
(en)
|
2006-11-07 |
2009-08-05 |
Sanofi-Aventis |
Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives
|
JP2010043001A
(ja)
|
2006-11-09 |
2010-02-25 |
Sanwa Kagaku Kenkyusho Co Ltd |
Glp−1誘導体とその用途
|
CA3007700A1
(en)
|
2006-11-09 |
2008-05-15 |
Boehringer Ingelheim International Gmbh |
Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
|
EP1921072A1
(en)
|
2006-11-10 |
2008-05-14 |
Laboratorios del Dr. Esteve S.A. |
1,2,3-Triazole derivatives as cannabinoid-receptor modulators
|
GB0622569D0
(en)
|
2006-11-11 |
2006-12-20 |
7Tm Pharma As |
Cannabinoid receptor modulators
|
AU2007320906A1
(en)
|
2006-11-13 |
2008-05-22 |
Pfizer Products Inc. |
Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
|
DE102006053636B4
(de)
|
2006-11-14 |
2008-09-18 |
Sanofi-Aventis Deutschland Gmbh |
Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
EP2083832B1
(de)
|
2006-11-14 |
2011-01-05 |
Sanofi-Aventis Deutschland GmbH |
Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
JP2010509388A
(ja)
|
2006-11-15 |
2010-03-25 |
ノバルティス アーゲー |
有機化合物
|
AU2007321283A1
(en)
|
2006-11-15 |
2008-05-22 |
Novartis Ag |
Heterocyclic derivatives as CETP inhibitors
|
CA2669915C
(en)
|
2006-11-17 |
2012-02-07 |
Pfizer Inc. |
Substituted bicyclocarboxyamide compounds
|
KR101373591B1
(ko)
|
2006-11-17 |
2014-03-12 |
마쓰다니가가꾸고오교가부시끼가이샤 |
글루코키나아제의 핵으로부터 세포질로의 이행의 촉진화제로서, 희소당의 기능의 이용
|
ES2382486T3
(es)
|
2006-11-20 |
2012-06-08 |
Bristol-Myers Squibb Company |
7,8-Dihidro-1,6-naftiridin-5(6H)-onas y compuestos bicíclicos relacionados como inhibidores de la dipeptidil peptidasa IV y procedimientos
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
AU2007334519A1
(en)
|
2006-12-14 |
2008-06-26 |
Merck Sharp & Dohme Corp. |
Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|